Vertex Pharmaceuticals
VRTX
#155
Rank
S$170.27 B
Marketcap
S$671.61
Share price
-2.94%
Change (1 day)
22.14%
Change (1 year)

EPS for Vertex Pharmaceuticals (VRTX)

EPS in 2026 (TTM): S$20.15

According to Vertex Pharmaceuticals's latest financial reports the company's current EPS (TTM) is S$20.21. In 2025 the company made an earnings per share (EPS) of S$19.96 an increase over its 2024 EPS that were of S-$2.66.

EPS history for Vertex Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$20.150.97%
2025S$19.96-850.97%
2024S-$2.66-114.67%
2023S$18.118.17%
2022S$16.7442.64%
2021S$11.74-12.67%
2020S$13.44128.01%
2019S$5.89-44.54%
2018S$10.63670.09%
2017S$1.38-327.66%
2016S-$0.61-79.65%
2015S-$2.98-26.43%
2014S-$4.0553.92%
2013S-$2.63316.33%
2012S-$0.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$8.62-57.37%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$7.55-62.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S-$4.00-119.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$1.28-93.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$5.83-71.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
S-$3.11-115.38%๐Ÿ‡บ๐Ÿ‡ธ USA